Cigna Corporation

NYSE:CI

Medical - Healthcare Plans

Healthcare
$285.37 -1.56%

-$4.44 today

Market cap
$75.20B
Beta
0.30
P/E (TTM)
11.7
EPS (TTM)
$23.95
Dividend yield
2.19%
52W Low $239.51High $338.89

Volume 2.49M

Average 1.61M

CI Revenue

Total income from selling goods and services before any costs are deducted; the top line of the income statement.

Cigna CorporationNYSE: CI

Revenue · Q3 FY2026 · quarter ended Sep 2026

Revenue grows in line with its trailing trend

Q3 FY2026 revenue of $73.68B rose 5.6% year over year, behind the +6.8% change in trailing-twelve-month revenue. Sequentially, it rose 2.8% from the prior quarter. Over 3 fiscal years it compounded at +15.1% a year.

Context

  • Revenue increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether revenue reaches the consensus estimate from 12 analysts of $288.3B (+4.9%) for the fiscal year ending Dec 2026, a slowdown from the +11.3% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterSep 2026
$73.68B+2.8% QoQ
Last fiscal yearDec 2025
$274.95B+11.3% YoY
LTMSep 2026
$286.32B+6.8% YoY
Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+5.6%+3.3%-2.3 pp
1 year+11.3%+4.9%-6.4 pp
3-year CAGR+15.1%+4.8%-10.3 pp
5-year CAGR+4.9%—
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Revenue history

USD · from the income statement

Latest · FY2025
274.95B USD
Year-over-year change
+11.3%
4-year CAGR
+12.1%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Revenue vs competitors

How CI compares with its peers on the latest reported figures

  • CI's LTM Sep 2026 revenue of $286.32B is the 3rd highest of the 9 companies compared; the peer median is $173.96B.
  • Its year-over-year change of +6.8% is the 6th highest of 9, against a peer median of +8.0%.
  • Over three fiscal years its annual growth of +15.1% compares with a peer median of +11.5%.
CI Competitors Peer median
Revenue for CI and competitors
Company Period LTM YoY 3-year CAGR
UNHUnitedHealth Group IncorporatedLTM Sep 2026$449.66B +3.3%+11.4%
CVSCVS Health CorporationLTM Jun 2026$415.09B +7.4%+7.6%
CICigna CorporationLTM Sep 2026$286.32B +6.8%+15.1%
ELVElevance Health Inc.LTM Sep 2026$201.83B +3.6%+8.3%
CNCCentene CorporationLTM Jun 2026$193.73B +8.7%+10.5%
HUMHumana Inc.LTM Sep 2026$154.19B +22.0%+11.7%
MOHMolina Healthcare, Inc.LTM Sep 2026$43.63B -2.1%+12.4%
OSCROscar Health, Inc.LTM Jun 2026$15.32B +42.8%+41.6%
ALHCAlignment Healthcare, Inc.LTM Mar 2026$4.26B +41.8%+40.2%
Peer median (excluding CI) $173.96B+8.0%+11.5%

Competitors are the stored peer set for CI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue174.07B180.52B195.27B247.12B274.95B
Cost of Revenue151.12B157.02B170.09B221.16B248.97B
Gross Profit22.95B23.5B25.18B25.96B25.99B
Gross Margin13.2%13.0%12.9%10.5%9.5%
Research & Development00000
Selling, General & Admin12.79B13.05B14.32B14.57B14B
Operating Expenses15.01B15.05B16.64B16.55B16.86B
Depreciation & Amortization2.92B2.94B3.04B2.78B2.78B
EBITDA11.09B11.52B12.07B12.47B11.75B
EBITDA Margin6.4%6.4%6.2%5.0%4.3%
Operating Income7.94B8.45B8.54B9.42B9.13B
Operating Margin4.6%4.7%4.4%3.8%3.3%
Interest Income00000
Interest Expense1.21B1.23B1.45B1.44B1.38B
Other Income / Expenses(1.15B)(53M)(3.02B)(4.15B)(1.54B)
Income Before Tax6.79B8.4B5.51B5.27B7.59B
Pre-Tax Margin3.9%4.7%2.8%2.1%2.8%
Income Tax Expense1.37B1.62B141M1.49B1.35B
Net Income5.37B6.7B5.16B3.43B5.96B
Net Margin3.1%3.7%2.6%1.4%2.2%
EPS (Basic)15.8921.6617.5712.2522.30
EPS (Diluted)15.7521.4117.3912.1222.17
Weighted Avg Shares337.96M313.07M296.88M280.29M265.95M
Weighted Avg Shares (Diluted)340.97M313.07M296.88M283.22M265.95M

Cigna Corporation

NYSE:CI

Intrinsic Alpha fair value

Locked

Current Price

$285.37

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.